SynEry is European research consortium from four partners and aims to leap innovation by providing a scalable, on demand artificial blood substitute, via design of an adequate Synthetic Erythrocyte facsimile that can be cost-effectively produced from the bottom-up using pharmaceutical-grade manufacturing facilities.
The SynEry project has received funding from the Horizon Europe programme under grant agreement No 101046894
Company Details
- Employees
- 23
- Founded
- -
- Address
- W. De Croylaan 42, Leuven,3001,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.synery.eu
- Keywords
- at Synergy Shipping PRIVATE LIMITED.
- HQ
- Leuven
Synery Questions
Synery's website is http://www.synery.eu
Synery's LinkedIn profile is https://be.linkedin.com/company/synery
Synery has
23 employees.
View email and phone details for 23
employees at Synery.
Synery's industry is
Biotechnology Research
Synery's top competitors are
Connectomx,
Artcell,
Pcr-4-All,
Ku Leuven Xct Core Facility,
Multicellular System Dynamics Lab,
Department Of Biosystems,
Mpacts,
Nanosoft,
Lammertyn Lab,
Biomimetics Ku Leuven.
Synery's categories are Biotechnology Research
Synery's founding year is 2022
